News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • DOJ asks for up to a 120-day pause before scheduling refunds after the Supreme Court tariff ruling, potentially freezing billions.
  • Argentina's Senate approved a broad labor reform shifting bargaining to firms and creating a severance fund to court global capital.
  • Denmark warns foreign interference is highly likely ahead of the March 24 snap election, citing Russia, the U.S., and China.
  • Scouting America and the Pentagon agreed to preserve military ties by requiring membership by biological sex at birth and removing DEI preferences.
  • Radiohead demanded ICE remove a social video using its song to depict immigrant violence, escalating a copyright dispute.

Latest Articles

Logistea Q4: Results Largely In Line; Board Proposes Higher Dividend

Logistea Q4: Results Largely In Line; Board Proposes Higher Dividend

Logistea reported fourth-quarter results that were broadly in line with market forecasts. Income from property management slightly exceeded consensus, net operating income matched expectations, and the company proposed a dividend above analyst forecasts. Modest property revaluations and a small dip in occupancy were offset by an improved cost of fi…

Jenoptik Sees 2026 as Return-to-Growth Year After Soft Q4 Orders

Jenoptik Sees 2026 as Return-to-Growth Year After Soft Q4 Orders

Jenoptik AG reported preliminary full-year 2025 sales of about €1.05 billion, a 6% decline year-over-year, and preliminary EBITDA of roughly €192 million, down 13% versus 2024. Fourth-quarter orders were weak, leaving the full-year book-to-bill at 0.95x and the Q4 book-to-bill at 0.75x. Management expects a return to revenue growth and margin impro…

Tietoevry Prioritizes Margin Gains as Revenue Outlook Remains Weak

Tietoevry Prioritizes Margin Gains as Revenue Outlook Remains Weak

Tietoevry has increased its 2026 cost-savings target and is focusing on margin improvement despite a soft top-line outlook. The company reported a 2% organic revenue decline in Q4 2025, significant progress on adjusted EBITA margin, and substantial headcount reductions. Management expects modestly negative to flat organic growth in 2026 but is aimi…

Saudi-Backed Midad Energy Agrees Term Sheet for Lukoil Assets

Saudi-Backed Midad Energy Agrees Term Sheet for Lukoil Assets

Saudi-backed Midad Energy has signed a term sheet to acquire Lukoil’s targeted overseas assets, submitting an all-cash offer held in escrow. The agreement, finalized in late January, is subject to approvals from multiple regulators, including the U.S. Treasury, as the parties work through sanctions-related constraints. The move highlights continued…

Barclays Boosts Zscaler Rating to Overweight While Trimming Price Target

Barclays Boosts Zscaler Rating to Overweight While Trimming Price Target

Barclays moved Zscaler (NASDAQ: ZS) from Equalweight to Overweight even as it reduced its price target from $264.00 to $228.00. The revised target still implies meaningful upside from the current share price, which has fallen sharply over the past six months. Barclays cites both durable customer economics and potential AI tailwinds while flagging a…

Aedifica posts 6.8% rise in rental income for FY2025, lifts EPS and dividend

Aedifica posts 6.8% rise in rental income for FY2025, lifts EPS and dividend

Aedifica reported rental income of €361 million for fiscal year 2025, a 6.8% increase year-over-year driven by external growth and steady like-for-like performance. EPRA earnings came in at €244.8 million and clean EPS rose to €5.15. The company also increased its dividend and maintained balance-sheet metrics, while reporting mixed occupancy trends…

Negotiations Between Sky and ITV Lose Momentum as Industry Focus Shifts to Warner Bros Discovery Battle

Negotiations Between Sky and ITV Lose Momentum as Industry Focus Shifts to Warner Bros Discovery Battle

Discussions over Sky’s potential £1.6 billion ($2.18 billion) acquisition of ITV’s broadcast channels and streaming platform have slowed in recent weeks. The talks - intended to create a top-three UK streaming service able to compete with global platforms - are being hampered by the complexity of separating ITV Studios and by distraction from the o…

Elkem to Swap Silicones Division for Bluestar Shares, Narrows Net Debt

Elkem to Swap Silicones Division for Bluestar Shares, Narrows Net Debt

Elkem ASA will divest its silicones business in a cashless share swap with major shareholder Bluestar, receiving about 383.3 million Bluestar shares. The move reduces reported net debt and leaves the remaining group with higher leverage metrics and a lower implied valuation multiple. Fourth-quarter results showed silicones outperformed expectations…

Safran Says CFM Will Try to Help Airbus but Sticks to Existing Commitments

Safran Says CFM Will Try to Help Airbus but Sticks to Existing Commitments

Safran CEO Olivier Andries said CFM will attempt to supply additional engines to Airbus this year if possible, while emphasizing that the company's primary obligation is to fulfill its pre-existing contractual commitments. CFM's forecast for a 15% rise in LEAP engine deliveries this year does not include assumptions about expanding its market share…

China Emerges as Main Channel for Foreign Cars Entering Russia, Data Shows

China Emerges as Main Channel for Foreign Cars Entering Russia, Data Shows

Registration figures and interviews indicate tens of thousands of foreign-brand cars are reaching Russia through China via gray-market routes. Many are produced in China with international partners or are reclassified zero-mileage vehicles sold in China then exported, enabling dealers to evade export restrictions introduced after Russia's 2022 inva…

Trianon posts robust 2025 results and returns dividend to shareholders

Trianon posts robust 2025 results and returns dividend to shareholders

Fastighets AB Trianon reported a strong fiscal 2025 showing, with profit from property management per share rising 27% and adjusted net asset value up 8% year-over-year. The company reinstated a dividend of SEK 0.25 per share, exceeded consensus expectations by 27%, and has guided for another year of double-digit profit growth in 2026.

European and Asian Equities Attract Heavy Flows as U.S. Stocks See Outflows

European and Asian Equities Attract Heavy Flows as U.S. Stocks See Outflows

In the week through February 11, global equity funds recorded a fifth consecutive weekly inflow of $25.54 billion, driven largely by substantial purchases of European and Asian equities. European funds logged $17.53 billion - the strongest weekly intake since at least 2022 - while Asian funds took in about $6.28 billion. U.S. equity funds experienc…

European Stocks Slip as AI Concerns and Mixed Results Cloud Markets

European Stocks Slip as AI Concerns and Mixed Results Cloud Markets

European equities fell on Friday as lingering worries over how new AI models may disrupt traditional business models weighed on sentiment. Mixed corporate reports from L’Oreal, Delivery Hero and Safran, together with disappointing gross margins at Cisco Systems, contributed to a cautious tone. The STOXX 600 was down about 0.3% and looked set to fin…

Stifel Affirms Buy on DexCom, Keeps $85 Price Target After Q4 Results

Stifel Affirms Buy on DexCom, Keeps $85 Price Target After Q4 Results

Stifel has reiterated a Buy rating on DexCom and maintained an $85.00 price target after the company’s fourth-quarter report, a level Stifel says is closely aligned with InvestingPro’s Fair Value assessment. The brokerage pointed to management’s upbeat commentary on sell-through trends that extended into early 2026, steady financial metrics and ups…

Sana Biotechnology: A high-risk, asymmetric swing trade on a biotech with a promising fusogen readout

Sana Biotechnology: A high-risk, asymmetric swing trade on a biotech with a promising fusogen readout

Sana (SANA) is a speculative long setup that pays to be small and patient. The company’s fusogen in vivo gene-editing work (published in Nature Biotechnology) is a real scientific milestone; the stock is cheap relative to upside if that program wins, but Sana faces cash burn, prior dilution and active litigation. Trade size accordingly and use a ha…

ConocoPhillips and partners to spend 20 billion kroner to revive Greater Ekofisk gas and condensate output

ConocoPhillips and partners to spend 20 billion kroner to revive Greater Ekofisk gas and condensate output

ConocoPhillips and its consortium will commit roughly 20 billion Norwegian crowns ($2.11 billion) to bring three fields in the Greater Ekofisk area back into production under the Previously Produced Fields (PPF) project. The plan targets gas and condensate recovery from Albuskjell, Vest Ekofisk and Tommeliten Gamma, which have been shut since 2019 …